COVID-19 Resistance with the ψ–Hamzah Model Treatment.

This article presents a comprehensive and innovative mathematical model, termed ψ–Hamzah, designed to address the complexities of resistant diseases, specifically COVID-19. The model integrates advanced mathematical principles, including fractional derivatives, fractal structures, and mixed integral forms, to simulate biological systems with memory-dependent dynamics. It leverages the capabilities of fractional calculus to capture the intricate, non-linear interactions between the immune system, pathogens, and external therapeutic interventions. The model is divided into multiple phases, starting from its theoretical foundation and progressing through detailed steps for simulating the disease's progression, vaccine response, and drug efficacy. Key features of the ψ–Hamzah model include the ability to account for non-Markovian memory effects, biological fractals, and adaptive virus mutations. Furthermore, the model incorporates the concept of fractional-order immunology, offering novel insights into the dynamics of immunity, viral replication, and the effectiveness of vaccines and antiviral treatments. The article presents the simulation results of the model, comparing its performance against traditional approaches like the SEIR model, demonstrating its superior predictive power in scenarios involving evolving viral strains, such as resistant variants of COVID-19. The model's ability to simulate vaccine efficacy and drug responses highlights its potential in designing and evaluating advanced therapeutic strategies, while its robustness is tested through numerical simulations that predict disease dynamics, immune responses, and treatment effectiveness over time. Finally, this article addresses the scientific, operational, and legal aspects of the ψ–Hamzah model, including its intellectual property rights, registration on platforms like Zenodo and ScienceOpen, and its potential use in clinical trials, with recommendations for adoption by global health organizations such as the WHO and FDA. The ψ–Hamzah model stands as a next-generation tool for understanding and combating resistant diseases, with far-reaching implications for future pandemic preparedness, vaccine development, and drug discovery. Key Terms: ψ–Hamzah model, fractional calculus, COVID-19, vaccine efficacy, drug resistance, non-Markovian memory, biological fractals, immunology, simulation, advanced therapeutic strategies, intellectual property.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-07-18
DOI
https://doi.org/10.5281/zenodo.16067171
Primary Topic
Ichthyology and Marine Biology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COVID-19 Resistance with the ψ–Hamzah Model Treatment.

Zenodo (CERN European Organization for Nuclear Research)
Ichthyology and Marine Biology
article

COVID-19 Resistance with the ψ–Hamzah Model Treatment.

article en

Abstract

This article presents a comprehensive and innovative mathematical model, termed ψ–Hamzah, designed to address the complexities of resistant diseases, specifically COVID-19. The model integrates advanced mathematical principles, including fractional derivatives, fractal structures, and mixed integral forms, to simulate biological systems with memory-dependent dynamics. It leverages the capabilities of fractional calculus to capture the intricate, non-linear interactions between the immune system, pathogens, and external therapeutic interventions. The model is divided into multiple phases, starting from its theoretical foundation and progressing through detailed steps for simulating the disease's progression, vaccine response, and drug efficacy. Key features of the ψ–Hamzah model include the ability to account for non-Markovian memory effects, biological fractals, and adaptive virus mutations. Furthermore, the model incorporates the concept of fractional-order immunology, offering novel insights into the dynamics of immunity, viral replication, and the effectiveness of vaccines and antiviral treatments. The article presents the simulation results of the model, comparing its performance against traditional approaches like the SEIR model, demonstrating its superior predictive power in scenarios involving evolving viral strains, such as resistant variants of COVID-19. The model's ability to simulate vaccine efficacy and drug responses highlights its potential in designing and evaluating advanced therapeutic strategies, while its robustness is tested through numerical simulations that predict disease dynamics, immune responses, and treatment effectiveness over time. Finally, this article addresses the scientific, operational, and legal aspects of the ψ–Hamzah model, including its intellectual property rights, registration on platforms like Zenodo and ScienceOpen, and its potential use in clinical trials, with recommendations for adoption by global health organizations such as the WHO and FDA. The ψ–Hamzah model stands as a next-generation tool for understanding and combating resistant diseases, with far-reaching implications for future pandemic preparedness, vaccine development, and drug discovery. Key Terms: ψ–Hamzah model, fractional calculus, COVID-19, vaccine efficacy, drug resistance, non-Markovian memory, biological fractals, immunology, simulation, advanced therapeutic strategies, intellectual property.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 53%
Ichthyology and Marine Biology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.